Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2019

Jun 20, 2019

30291_dirs_2019-06-20_388d9f23-6dfd-494f-9315-e94bb3662cbd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2019-06-19

Reporting Person: PAPADOPOULOS STELIOS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-06-19 Common Stock A 1905 Acquired 5095 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10831 Indirect
Common Stock 17375 Indirect